The Synergistic Combination of the Farnesyl Transferase Inhibitor Lonafarnib and Paclitaxel Enhances Tubulin Acetylation and Requires a Functional Tubulin Deacetylase

Ítems similars

• Farnesyl Transferase Expression Determines Clinical Response to the Docetaxel-Lonafarnib Combination in Patients with Advanced Malignancies
  per: Kauh, John, et al.
  Publicat: (2011)
• Resistance to Microtubule-Stabilizing Drugs Involves Two Events β-Tubulin Mutation in One Allele Followed by Loss of the Second Allele
  per: Wang, Yuefang, et al.
  Publicat: (2005)
• Microtubule disruption targets HIF-1α mRNA to cytoplasmic P-bodies for translational repression
  per: Carbonaro, Marisa, et al.
  Publicat: (2011)
• Peloruside- and Laulimalide-Resistant Human Ovarian Carcinoma Cells Have βI-Tubulin Mutations and Altered Expression of βII- and βIII-Tubulin Isotypes
  per: Kanakkanthara, Arun, et al.
  Publicat: (2011)
• Microtubules Regulate Hypoxia-inducible Factor-1α Protein Trafficking and Activity: IMPLICATIONS FOR TAXANE THERAPY
  per: Carbonaro, Marisa, et al.
  Publicat: (2012)